CX3CL1 and neoplasm: To determine whether CX3CL1 could function as a potential marker of metastasis and poor prognosis in patients with aggressive OSCC, 45 patients with cervical LN metastasis underwent CX3CL1 immunostaining analysis of the primary tumor and metastatic LNs.